[ET Net News Agency, 29 October 2021] Macquarie raised its target price for Bud APAC
(01876) to HK$29.6 from HK$28.9 and maintained its "outperform" rating.
The research house said it raises 2021/22 EBITDA estimates by 2.0%/2.7% driven by APAC
West ASP growth. (RC)